文献速递血管炎

局限性肉芽肿性多血管炎与系统性肉芽肿性多血管炎:法国血管炎研究组登记研究数据

Localized versus systemic granulomatosis with polyangiitis: data from the French Vasculitis Study Group Registry.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该登记研究比较了局限性肉芽肿性多血管炎(L-GPA)与系统性GPA(S-GPA)的诊断特征及长期结局。795例患者中79例(10%)为L-GPA,L-GPA患者更年轻、鞍鼻或声门下狭窄更常见、PR3-ANCA阳性更少;两组复发风险相似但复发模式不同,L-GPA总生存率更高,约四分之一L-GPA进展为S-GPA。

要点

  • L-GPA患者较S-GPA更年轻,鞍鼻畸形或声门下狭窄更常见,PR3-ANCA阳性更少。
  • L-GPA与S-GPA复发风险相似,但L-GPA更常见耳鼻喉和肺部复发,总生存率更高。
  • 约22.8%的L-GPA在中位3.5年随访中进展为S-GPA,多与难治性疾病相关。

核心结论

  • L-GPA与S-GPA复发风险相似但复发模式不同,L-GPA总生存率更高,约四分之一L-GPA进展为S-GPA但无终末期器官受累。

研究设计与样本

  • 基于法国血管炎研究组登记数据,应用EULAR的L-GPA和S-GPA定义,比较795例患者中79例(10%)L-GPA与S-GPA的诊断特征及长期结局。

主要发现

  • L-GPA vs S-GPA患者诊断时分别更年轻、更常有鞍鼻畸形或声门下狭窄、更少PR3-ANCA阳性。
  • L-GPA vs S-GPA诱导治疗更少含CYC但更常用MTX联合糖皮质激素;64%接受MTX治疗者在诊断后18个月内出现疾病进展。
  • L-GPA与S-GPA各时间点无复发生存概率、复发率和难治性疾病率相当,但L-GPA更常见耳鼻喉和肺部复发且总生存率更高(P<0.02)。
  • 中位随访3.5年期间,18例(22.8%)L-GPA进展为S-GPA,或为缓解后复发或更常见于难治性疾病背景。
  • L-GPA患者耳鼻喉相关损伤更多。

临床怎么用

  • L-GPA患者需长期监测疾病进展及耳鼻喉和肺部复发,警惕约四分之一患者进展为S-GPA。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the main features at diagnosis and evolution over time of patients with localized granulomatosis with polyangiitis (L-GPA) compared with those of systemic GPA (S-GPA). METHODS: EULAR definitions of L-GPA, i.e. upper and/or lower respiratory tract involvement, and S-GPA were applied to patients from the French Vasculitis Study Group Registry. L-GPA and S-GPA patients' characteristics at diagnosis and long-term outcomes were analysed and compared. RESULTS: Among the 795 Registry patients, 79 (10%) had L-GPA. Their main clinical manifestations were rhinitis, lung nodules, sinusitis and otitis. L-GPA vs S-GPA patients at diagnosis, respectively, were younger, more frequently had saddle nose deformity or subglottic stenosis and were less often PR3-ANCA-positive. L-GPA vs S-GPA induction therapy less frequently included CYC but more often a combination of MTX and glucocorticoids; 64% of MTX-treated patients experienced disease progression within 18 months post-diagnosis. L- and S-GPA patients' estimated relapse-free-survival probabilities, relapse rates and refractory disease rates at each time point were comparable, but L-GPA patients had more frequent ENT and lung relapses, and higher overall survival rates (P<0.02). Over a median follow-up of 3.5 years, 18 (22.8%) L-GPA progressed to S-GPA, either as a relapse after a period in remission or more frequently in the context of refractory disease. L-GPA patients experienced more ENT-related damage. CONCLUSIONS: The relapse risks of L-GPA and S-GPA were similar, but relapse patterns differed and L-GPA overall survival rate was higher. About one-quarter of L-GPA patients developed S-GPA over time, but without end-stage organ involvement.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Iudici M, Pagnoux C, Courvoisier DS, et al. Localized versus systemic granulomatosis with polyangiitis: data from the French Vasculitis Study Group Registry. Rheumatology (Oxford). 2022. PMID: 34542599. doi:10.1093/rheumatology/keab719

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。